BRK-B vs. NOV.DE
BRK-B (Berkshire Hathaway Inc.) and NOV.DE (Novo Nordisk A/S) are both stocks. BRK-B operates in Insurance - Diversified (Financial Services), while NOV.DE operates in Biotechnology (Healthcare). Over the past 10 years, BRK-B returned 13.22%/yr vs 17.53%/yr for NOV.DE. At a 0.17 correlation, their price movements are largely independent.
Performance
BRK-B vs. NOV.DE - Performance Comparison
Loading charts...
Different Trading Currencies
BRK-B is traded in USD, while NOV.DE is traded in EUR. To make them comparable, the NOV.DE values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BRK-B achieves a -2.67% return, which is significantly higher than NOV.DE's -11.73% return. Over the past 10 years, BRK-B has underperformed NOV.DE with an annualized return of 13.22%, while NOV.DE has yielded a comparatively higher 17.53% annualized return.
BRK-B
- 1D
- 0.71%
- 1M
- 0.77%
- YTD
- -2.67%
- 6M
- -2.06%
- 1Y
- -0.22%
- 3Y*
- 13.30%
- 5Y*
- 11.27%
- 10Y*
- 13.22%
NOV.DE
- 1D
- 0.10%
- 1M
- -6.50%
- YTD
- -11.73%
- 6M
- -9.41%
- 1Y
- -43.15%
- 3Y*
- 6.73%
- 5Y*
- 19.17%
- 10Y*
- 17.53%
BRK-B vs. NOV.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BRK-B Berkshire Hathaway Inc. | -2.67% | 10.89% | 27.09% | 15.46% | 3.31% | 28.95% | 2.37% | 10.93% | 3.01% | 21.62% |
NOV.DE Novo Nordisk A/S | -11.73% | -38.90% | -14.63% | 211.15% | 25.23% | 62.99% | 27.33% | 36.04% | -11.70% | 59.25% |
Correlation
The correlation between BRK-B and NOV.DE is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2007 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BRK-B vs. NOV.DE — Risk / Return Rank
BRK-B
NOV.DE
BRK-B vs. NOV.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Berkshire Hathaway Inc. (BRK-B) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BRK-B | NOV.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.82 | ||
| Sortino ratioReturn per unit of downside risk | +1.12 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 0.85 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.02 | -0.80 | +0.77 |
| Martin ratioReturn relative to average drawdown | -0.05 | -1.18 | +1.13 |
Loading charts...
Drawdowns
BRK-B vs. NOV.DE - Drawdown Comparison
The maximum BRK-B drawdown since its inception was -53.86%, smaller than the maximum NOV.DE drawdown of -74.44%. Use the drawdown chart below to compare losses from any high point for BRK-B and NOV.DE.
Loading charts...
Drawdown Indicators
| BRK-B | NOV.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.86% | -74.44% | +20.58% |
Max Drawdown (1Y)Largest decline over 1 year | -9.42% | -53.90% | +44.48% |
Max Drawdown (3Y)Largest decline over 3 years | -14.95% | -74.44% | +59.49% |
Max Drawdown (5Y)Largest decline over 5 years | -26.58% | -74.44% | +47.86% |
Max Drawdown (10Y)Largest decline over 10 years | -29.57% | -74.44% | +44.87% |
Current DrawdownCurrent decline from peak | -9.36% | -67.97% | +58.61% |
Average DrawdownAverage peak-to-trough decline | -11.07% | -12.36% | +1.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 34.98% | -30.45% |
Volatility
BRK-B vs. NOV.DE - Volatility Comparison
The current volatility for Berkshire Hathaway Inc. (BRK-B) is 3.95%, while Novo Nordisk A/S (NOV.DE) has a volatility of 9.91%. This indicates that BRK-B experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BRK-B | NOV.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.95% | 9.91% | -5.96% |
Volatility (6M)Calculated over the trailing 6-month period | 10.78% | 38.82% | -28.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.38% | 51.60% | -37.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.12% | 57.41% | -40.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.44% | 44.54% | -25.10% |
Dividends
BRK-B vs. NOV.DE - Dividend Comparison
BRK-B has not paid dividends to shareholders, while NOV.DE's dividend yield for the trailing twelve months is around 4.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRK-B Berkshire Hathaway Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NOV.DE Novo Nordisk A/S | 4.10% | 3.54% | 1.59% | 1.02% | 2.36% | 2.54% | 3.97% | 4.18% | 5.34% | 4.55% | 7.38% | 2.50% |
Financials
BRK-B vs. NOV.DE - Financials Comparison
This section allows you to compare key financial metrics between Berkshire Hathaway Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BRK-B and NOV.DE have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for BRK-B and NOV.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer